Sionna Therapeutics, Inc. (SION)
NASDAQ: SION · Real-Time Price · USD
42.82
+0.02 (0.05%)
At close: May 29, 2026, 4:00 PM EDT
42.75
-0.07 (-0.16%)
After-hours: May 29, 2026, 7:13 PM EDT

Sionna Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22
Cash & Equivalents
63.3258.4537.7938.5254.84
Short-Term Investments
152.83177.43109.75-27.77
Cash & Short-Term Investments
216.15235.88147.5438.5282.61
Cash Growth
-19.84%59.88%283.01%-53.37%-
Other Current Assets
4.815.543.460.691.22
Total Current Assets
220.96241.42150.9939.2183.83
Net Property, Plant & Equipment
8.759.1510.311.732.57
Long-Term Investments
73.7874.4220.51--
Other Long-Term Assets
1.550.963.961.011.01
Total Assets
305.04325.95185.7551.9587.37
Accounts Payable
2.110.771.190.720.56
Accrued Expenses
6.359.678.166.597.7
Current Portion of Leases
1.321.271.070.73-
Total Current Liabilities
9.7811.7110.428.048.25
Long-Term Leases
7.067.418.689.75-
Total Long-Term Liabilities
7.067.418.689.75-
Total Liabilities
16.8319.1219.117.798.25
Common Stock
0.050.050.0100
Additional Paid-in Capital
571.38562.6174.522.23
Accumulated Other Comprehensive Income
-0.080.540.37--0.02
Retained Earnings
-283.13-256.35-181.09-119.4-72.14
Total Common Shareholders' Equity
288.21306.83-163.71-114.88-69.92
Minority Interest
--330.37149.04149.04
Shareholders' Equity
288.21306.83166.6634.1679.12
Total Liabilities & Equity
305.04325.95185.7551.9587.37
Total Debt
8.388.689.7510.480
Net Cash (Debt)
207.77227.21137.7928.0482.61
Net Cash Growth
-8.55%64.89%391.33%-66.05%-
Net Cash Per Share
4.675.6835.719.560.03
Book Value
288.21306.83-163.71-114.88-69.92
Book Value Per Share
6.487.68-42.43-39.17-0.03
Tangible Book Value
288.21306.83-163.71-114.88-69.92
Tangible Book Value Per Share
6.487.68-42.43-39.17-0.03
SEC Filings: 10-K · 10-Q